The ability of CatX inhibition and concomitant CatB and CatX inhibition to reduce tumor cell migration was examined with the scratch assay (for MCF-10A neoT and MMTV-PyMT cells) and the xCELLigence system (for MCF-10A neoT cells). This evidence concerns the gene TYRP1 and neoplasm.